172@29@17@106!~!172@29@0@53!~!|news|business|earnings|bharat-immuno-standalone-september-2019-net-sales-at-rs-8-10-crore-up-73-39-y-o-y-4595101.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Nov 01, 2019 03:07 PM IST | Source: Moneycontrol.com

Bharat Immuno Standalone September 2019 Net Sales at Rs 8.10 crore, up 73.39% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Bharat Immunologicals and Biologicals Corporation are:

Net Sales at Rs 8.10 crore in September 2019 up 73.39% from Rs. 4.67 crore in September 2018.

Quarterly Net Loss at Rs. 5.66 crore in September 2019 down 125.77% from Rs. 2.51 crore in September 2018.

Close

EBITDA stands negative at Rs. 6.52 crore in September 2019 down 85.75% from Rs. 3.51 crore in September 2018.

Bharat Immuno shares closed at 6.38 on October 31, 2019 (BSE) and has given -20.15% returns over the last 6 months and -53.77% over the last 12 months.

Bharat Immunologicals and Biologicals Corporation
Standalone Quarterly Resultsin Rs. Cr.
Sep'19Jun'19Sep'18
Net Sales/Income from operations8.107.004.67
Other Operating Income------
Total Income From Operations8.107.004.67
EXPENDITURE
Consumption of Raw Materials44.533.2410.52
Purchase of Traded Goods------
Increase/Decrease in Stocks-34.293.80-6.67
Power & Fuel------
Employees Cost2.552.562.30
Depreciation0.060.200.10
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses2.013.142.12
P/L Before Other Inc. , Int., Excpt. Items & Tax-6.75-5.94-3.71
Other Income0.171.840.10
P/L Before Int., Excpt. Items & Tax-6.58-4.09-3.61
Interest1.250.900.09
P/L Before Exceptional Items & Tax-7.82-5.00-3.70
Exceptional Items------
P/L Before Tax-7.82-5.00-3.70
Tax-2.16-1.54-1.19
P/L After Tax from Ordinary Activities-5.66-3.46-2.51
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period-5.66-3.46-2.51
Equity Share Capital43.1843.1843.18
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS-1.28-0.80-0.58
Diluted EPS-1.28-0.80-0.58
EPS After Extra Ordinary
Basic EPS-1.28-0.80-0.58
Diluted EPS-1.28-0.80-0.58
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on Nov 1, 2019 03:05 pm
Sections